Real-time enrollment status for this immune thrombocytopenia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 12:07 PM UTC
| NCT Number | NCT06722235 |
| Recruiting Status | Recruiting |
| Condition | Immune Thrombocytopenia |
| Phase | Clinical Trial |
| Target Enrollment | 171 participants |
| Active Locations | 12 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | January 28, 2026 (Jan 28, 2026) |
As of March 2, 2026: Clinical trial NCT06722235 is currently recruiting participants. This clinical trial study for immune thrombocytopenia is actively seeking new participants at 12 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06722235 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 12 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06722235 was last updated Jan 28, 2026 (January 28, 2026). HelloStudys verifies this status automatically.